Evidence map›Paper›PMID 34827289›Full record

ArticleAntibiotics (Basel, Switzerland)2021

How Adding Chlorhexidine or Metallic Nanoparticles Affects the Antimicrobial Performance of Calcium Hydroxide Paste as an Intracanal Medication: An In Vitro Study.

Kadiatou Sy, Kevimy Agossa, Mickaël Maton, Henry Chijcheapaza-Flores, Bernard Martel, Florence Siepmann, Etienne Deveaux, Nicolas Blanchemain, Christel Neut

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Kadiatou SyU1008-Controlled Drug Delivery Systems and Biomaterials, Inserm, CHU Lille, University of Lille, 59000 Lille, France.
Kevimy AgossaU1008-Controlled Drug Delivery Systems and Biomaterials, Inserm, CHU Lille, University of Lille, 59000 Lille, France.ORCID 0000-0003-4305-1353
Mickaël MatonU1008-Controlled Drug Delivery Systems and Biomaterials, Inserm, CHU Lille, University of Lille, 59000 Lille, France.
Henry Chijcheapaza-FloresU1008-Controlled Drug Delivery Systems and Biomaterials, Inserm, CHU Lille, University of Lille, 59000 Lille, France.ORCID 0000-0002-7555-0109
Bernard MartelUMR 8207, UMET-Unité Matériaux et Transformations, CNRS-Centre National de la Recherche Scientifique, INRA-Institut National de la Recherche Agronomique, ENSCL-Ecole Nationale Supérieure de Chimie de Lille, University of Lille, 59655 Lille, France.
Florence SiepmannU1008-Controlled Drug Delivery Systems and Biomaterials, Inserm, CHU Lille, University of Lille, 59000 Lille, France.ORCID 0000-0001-6337-0234
Etienne DeveauxU1008-Controlled Drug Delivery Systems and Biomaterials, Inserm, CHU Lille, University of Lille, 59000 Lille, France.
Nicolas BlanchemainU1008-Controlled Drug Delivery Systems and Biomaterials, Inserm, CHU Lille, University of Lille, 59000 Lille, France.
Christel NeutU1286 Infinite-Institute for Translational Research in Inflammation, Inserm, CHU Lille, University of Lille, 59000 Lille, France.ORCID 0000-0002-2036-6152
Inserm · FRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of our study was to explore the potential value of metallic (Ag, Cu, and Zn) salts, polymer/metallic nanoparticles, and chlorhexidine (CHX) for improving the antimicrobial activity of calcium hydroxide (CH) against

Indexed as

antimicrobial propertiescalcium hydroxidechlorhexidinecopperendodontic infectionsmechanical propertiesnanoparticlerheological propertiessilverzinc

Identifiers

PMID34827289
PMCPMC8614750
OpenAlexW3211677720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.